The wearable, noninvasive CardioTag is designed to capture electrocardiogram, photoplethysmogram, and seismocardiogram signals, as well as heart rate and pulse rate.

FDA grants fast track designation to CLD-201, an innovative therapy for soft tissue sarcoma, enhancing its development and ...

Hong Kong-based CSPC will receive $120 million from Madrigal under the deal. Elsewhere, Apellis and PTC Therapeutics won FDA approvals.

Researchers from Southern Medical University and collaborators report the identification of FDA‑approved compounds that may ...

A new technology that harnesses artificial intelligence (AI) to analyze mammograms and improve the accuracy of predicting a ...

Medical AI company Cardiosense has claimed an FDA clearance for its CardioTag device, a wearable sensor that provides a ...

A new technology that harnesses AI to analyze mammograms and improve the accuracy of predicting a woman's personalized ...

While colleges across the nation are adapting their curricula to harness the power of generative AI, U.S. medical schools ...

The Food and Drug Administration’s polarizing vaccine chief is leaving the agency after a brief tenure that drew the ire of ...

Dr. Vinay Prasad, a vocal critic of the FDA before joining its ranks, has stepped down from his leadership post at the agency ...

Cardiosense, a medical AI company transforming cardiovascular disease management, today announced that the U.S. Food and Drug ...

Abuse allegations and infighting helped kill a campaign to legalize MDMA for medical use. Trumpworld is giving the therapy’s ...